Nanjing Delova Biotech Co., Ltd.
PrivateLast Round
Series B
Extension
Apr 2, 2024
Total Funding Raised
$51.35M
Company Overview
Nanjing Delova Biotech Co., Ltd. is a biopharmaceutical company that develops innovative, non-opioid analgesic drug formulations and long-acting injection technology platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing Delova Biotech Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nanjing Delova Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 2, 2024 | ||||
| Series B | Jan 1, 2023 | ||||
| Series A | Jun 16, 2021 | ||||
| Pre Seed | Sep 14, 2020 | ||||
| Angel | Aug 25, 2017 |
Nanjing Delova Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongqi Capital | Series B Extension |
| Legend Capital | Series A, Pre Seed |
| Shengjing Jiacheng | Series B Extension |
| MPC | Series A |
| Yingdi Capital | Angel, Pre Seed |
| Hyfinity Investments | Series B Extension |
Nanjing Delova Biotech Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanjing Delova Biotech Co., Ltd.'s valuation, stock price, and market status.